Synergistic treatment of cancer using immunomers in conjunction with chemotherapeutic agents
US7875594B2 · kind B2 · utility
8Cited by
17References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 28, 2008 |
| Grant date | Jan 25, 2011 |
| Priority date | — |
| Expiry date | Mar 21, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/24
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the therapeutic use of immunostimulatory oligonucleotides and/or immunomers in combination with chemotherapeutic agents to provide a synergistic therapeutic effect.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.